Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Allergan challenges government's 'off-label' use

Company seeks to share information on off-label usage of Botox.

FoodConsumer.org reports that a suit recently filed by Allergan regarding Botox (not the cosmetic version) could be precedent-setting. A press release on Allergan’s Web site says, “Under current law, drugs are approved by the FDA for specific uses. Once a drug is approved, physicians may exercise their informed medical judgment to prescribe the drug for any use, including off-label uses. It is estimated that approximately 20 percent of all prescriptions in the United States are used by physicians for off-label indications.” The FDA offers information on “off-label” and investigational use of marketed drugs, biologics, and medical devices.

Allergan, Inc., an Irvine, CA-based health care company focused on discovering, developing, and commercializing pharmaceuticals, biologics, and medical devices, contends in the press release: “The lawsuit only seeks to permit Allergan to proactively provide the medical community with truthful, important information about common off-label uses of Botox. Moreover, far from seeking freedom from regulation, Allergan hopes this suit will lead to clear regulatory guidance on how it can lawfully provide accurate and relevant information on the full range of issues physicians should consider in determining the best therapies for their patients.”

FoodConsumer.org’s Rachel Howell Stockton concludes, “This is a precedent setting case, as Botox’s unique position has made it possible for some lessening of FDA regulations. However, critics say that the FDA would be rendered “useless” if drug companies are able to go full throttle with their advertising.”

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report